Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $132.60 | Total: $663.00 |
| 1 | 10 | $112.32 | Total: $1,123.20 |
| 1 | 25 | $95.16 | Total: $2,379.00 |
| 1 | 50 | $81.12 | Total: $4,056.00 |
| 1 | 100 | $70.20 | Total: $7,020.00 |
Overview
PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer.
Chemical Properties
| Molecular Formula | C19H19FN4O2S |
| Molecular Weight | 386.44 |
| CAS Numbers | 2127107-15-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | N(C(N)=O)C1=C(C(N[C@H]2CCCNC2)=O)SC(C#CC3=CC(F)=CC=C3)=C1 |
Storage and Handling
0C Short Term, -20C Long Term